Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  6. News
  7. Summary
    603456   CNE100001W36

ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD

(603456)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021

10/28/2021 | 05:30am EST

Zhejiang Jiuzhou Pharmaceutical Co., Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 3,004.23 million compared to CNY 1,745.84 million a year ago. Revenue was CNY 3,004.23 million compared to CNY 1,745.84 million a year ago. Net income was CNY 473.12 million compared to CNY 239.37 million a year ago. Basic earnings per share from continuing operations was CNY 0.57 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 0.57 compared to CNY 0.3 a year ago.


© S&P Capital IQ 2021
All news about ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
01/04Zhejiang Jiuzhou Pharmaceutical Co., Ltd signed Investment Agreement to acquire a 25.8%..
CI
2021Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it has received CNY 30..
CI
2021Zhejiang Jiuzhou Pharmaceutical Co., Ltd completed the acquisition of Teva Pharmaceutic..
CI
2021Zhejiang Jiuzhou Pharmaceutical Co., Ltd signed a Equity Transfer Agreement to acquire ..
CI
2021Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months E..
CI
2021Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive ..
CI
2021ZHEJIANG JIUZHOU PHARMACEUTICAL CO., : 603456) added to S&P Global BMI Index
CI
2021ZHEJIANG JIUZHOU PHARMACEUTICAL CO., : 603456) added to FTSE All-World Index
CI
2021Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year End..
CI
2021Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter..
CI
More news
Financials
Sales 2021 3 816 M 601 M 601 M
Net income 2021 633 M 99,7 M 99,7 M
Net Debt 2021 - - -
P/E ratio 2021 67,1x
Yield 2021 0,71%
Capitalization 42 462 M 6 688 M 6 689 M
Capi. / Sales 2021 11,1x
Capi. / Sales 2022 8,51x
Nbr of Employees 3 586
Free-Float 51,1%
Chart ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Duration : Period :
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 51,00 CNY
Average target price 69,60 CNY
Spread / Average Target 36,5%
EPS Revisions
Managers and Directors
Zhi Hong Chen General Manager & Director
Yu Jie Sha Chief Financial Officer
Li Rong Hua Chairman
Meng Sheng Sun Chairman-Supervisory Board
Yuan Qiang Li Director-Technology, Research & Development